132 related articles for article (PubMed ID: 10427622)
1. Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease.
Braun N; Risler T
Ther Apher; 1999 Aug; 3(3):240-5. PubMed ID: 10427622
[TBL] [Abstract][Full Text] [Related]
2. Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis.
Kriaa F; Laurian Y; Hiesse C; Tchernia G; Charpentier B
Nephrol Dial Transplant; 1995; 10 Suppl 6():108-10. PubMed ID: 8524477
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
[TBL] [Abstract][Full Text] [Related]
4. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose.
Braun N; Gutenberger S; Erley CM; Risler T
Transfus Sci; 1998 Mar; 19 Suppl():25-31. PubMed ID: 10178689
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
7. Protein A immunoadsorption: immunomodulatory effects.
Kiprov DD
Prog Clin Biol Res; 1990; 337():449-52. PubMed ID: 2191336
[No Abstract] [Full Text] [Related]
8. Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an immune thrombocytopenic purpura patient as a consequence of extracorporeal protein A immunoadsorption.
Balint JP; Cochran SK; Jones FR
Artif Organs; 1995 Jun; 19(6):496-9. PubMed ID: 8526787
[TBL] [Abstract][Full Text] [Related]
9. High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus.
Funauchi M; Ikoma S; Enomoto H; Ohno M; Kinoshita K; Horiuchi A; Kurata N
Intern Med; 1996 May; 35(5):367-72. PubMed ID: 8797048
[TBL] [Abstract][Full Text] [Related]
10. Adverse clinical effects of immune sorption with staphylococcal protein A columns.
Huestis DW; Morrison FS
Transfus Med Rev; 1996 Jan; 10(1):62-70. PubMed ID: 8787931
[No Abstract] [Full Text] [Related]
11. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
Somnier FE; Langvad E
J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
[TBL] [Abstract][Full Text] [Related]
12. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
Funauchi M; Ikoma S; Imada A; Kanamaru A
J Clin Lab Immunol; 1997; 49(2):47-57. PubMed ID: 9819673
[TBL] [Abstract][Full Text] [Related]
13. Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.
Kenderov A; Minkova V; Mihailova D; Giltiay N; Kyurkchiev S; Kehayov I; Kazatchkine M; Kaveri S; Pashov A
Clin Exp Immunol; 2002 Jul; 129(1):169-76. PubMed ID: 12100037
[TBL] [Abstract][Full Text] [Related]
14. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
Koll RA
Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic immunoadsorption--its role in clinical practice.
Braun N; Kadar JG; Risler T
Transfus Sci; 1998 Mar; 19 Suppl():65-9. PubMed ID: 10178698
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
17. C1q: a multifunctional ligand for a new immunoadsorption treatment.
Hiepe F; Pfüller B; Wolbart K; Bruns A; Leinenbach HP; Hepper M; Schössler W; Otto V
Ther Apher; 1999 Aug; 3(3):246-51. PubMed ID: 10427623
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
19. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
